Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1

Abstract

The Wilms' tumour suppressor gene, WT1, encodes multiple nuclear protein isoforms, all containing four C-terminal zinc finger motifs. WT1 proteins can both activate and repress putative target genes in vitro, although the in vivo relevance of these putative target genes is often unverified. WT1 mutations can result in Wilms' tumour and the Denys-Drash Syndrome (DDS) of infantile nephropathy, XY pseudohermaphroditism and predisposition to Wilms' tumour. We have established stable transfectants of the mouse mesonephric cell line, M15, which express WT1 harbouring a common DDS point mutation (R394W). A comparison of the expression profiles of M15 and transfectant C2A was performed using Nylon-based arrays. Very few genes showed differential expression. However Wnt-4, a member of the Wnt gene family of secreted glycoproteins, was downregulated in C2A and other similar clones. Doxycycline induction of WT1-A or WT1-D expression in HEK293 stable transfectants also elicited an elevation in Wnt4 expression. Wnt4 is critical for the mesenchyme-to-epithelial transition during kidney development, making it an attractive putative WT1 target. We have mapped human Wnt-4 gene to chromosome 1p35-36, a region of frequent LOH in WT, have characterized the genomic structure of the human Wnt-4 gene and isolated 9 kb of immediate promoter. While several potential WT1 binding sites exist within this promoter, reporter analysis does not strongly support the direct regulation of Wnt4 by WT1. We propose that Wnt-4 regulation by WT1 occurs at a more distant promoter or enhancer site, or is indirect.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bergstein I, Eisenberg LM, Bhalerao J, Jenkins NA, Copeland NG, Osborne MP, Bowcock AM, Brown AM . 1997 Genomics 46: 450–458

  • Borel F, Barilla KC, Hamilton TB, Iskander M, Romaniuk PJ . 1996 Biochem. J. 35: 12070–12076

  • Bruening W, Pelletier J . 1996 J. Biol. Chem. 271: 8646–9654

  • Call K, Glaser T, Ito C, Buckler A, Pelletier J, Haber D, Rose E, Kral A, Yeger H, Lewis W, Jones C, Housman D . 1990 Cell 60: 509–520

  • Chomczynski P, Sacchi N . 1987 Anal. Biochem. 162: 156–159

  • Christiansen JH, Monkley SJ, Wainwright BJ . 1996 Oncogene 12: 2705–2711

  • Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, Bornstein P, Binetruy B, Cabon F . 1999 Oncogene 20: 3143–3151

  • Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA . 1997 Induction of p21 by the Wilms' tumor suppressor gene WT1 Cancer Res. 57: 1429–1434

    CAS  PubMed  Google Scholar 

  • Evers R, Smid A, Rudloff U, Lottspeich F, Grummt I . 1995 EMBO J. 14: 1248–1256

  • Francke U, Holmes LB, Atkins L, Ricciardi VM . 1979 Cytogenet. Cell Genet. 24: 185–192

  • Fraizer GC, Wu YJ, Hewitt SM, Maity T, Ton CC, Huff V, Saunders G . 1994 J. Biol. Chem. 269: 8892–8900

  • Gavin BJ, McMahon JA, McMahon AP . 1990 Development 3: 2319–2332

  • Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP . 1990 Nature 343: 774–778

  • Gossen MS, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H . 1995 Science 268: 1766–1769

  • Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE . 1991 Proc. Natl. Acad. Sci. USA 88: 9618–9622

  • Hamilton TB, Barilla KC, Romaniuk PJ . 1995 Nucleic Acids Res. 23: 277–284

  • Hewitt SM, Hamada S, McDonnell TJ, Rauscher III FJ, Saudners GF . 1995 Cancer Res. 55: 5386–5389

  • Holmes GP, Boterashvili S, English M, Wainwright BJ, Licht JD, Little M . 1997 Biochem. Biophys. Res. Commun. 233: 723–728

  • Hosono S, Luo X, Hyink DP, Schnapp LM, Wilson PD, Burrow CR, Reddy J, Atweh G, Licht JD . 1999 Oncogene 18: 417–427

  • Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA, de Jong PJ . 1994 Nat. Genet. 6: 84–89

  • Kim J, Prawitt D, Bardeesy N, Torban E, Vicaner C, Goodyer P, Zabel B, Pelletier J . 1999 Mol. Cell Biol. 19: 2289–2299

  • Koester R, Ridder R . 1999 Cancer Res. 59: 3880–3882

  • Ku M, Melton DA . 1993 Development 119: 1161–1173

  • Larsson SH, Charlieu J-P, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND . 1995 Cell 81: 391–401

  • Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA . 1999 Cell 98: 663–673

  • Li RS, Law GL, Seifert RA, Romaniuk PJ, Morris DR . 1999 Exp. Cell Res. 247: 257–266

  • Little M, Holmes G, Bickmore W, van Heyningen V, Hastie N, Wainwright B . 1995 Hum. Mol. Genet. 4: 351–358

  • Little MH, Pell L, Holmes GP, Duarte A, Caricasole A, Ward A, Wainwright BJ . 1996 Oncogene 13: 1461–1469

  • Little M, Wells C . 1997 Hum. Mutat. 9: 209–225

  • Little MH, Holmes G, Walsh P . 1999 Bioessays 12: 191–202

  • Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher III FJ . 1991 Science 253: 1550–1553

  • Matsunaga E . 1981 Hum. Genet. 57: 231–246

  • Miller R, Fraumeni J, Manning M . 1964 New England J. Med. 270: 922–927

  • Mizushima S, Nagata S . 1990 Nucleic Acids Res. 18: 5322

  • Moshier JA, Skunca M, Wu W, Boppana SM, Rauscher III FJ, Dosescu J . 1996 Nucleic Acids Res. 24: 1149–1157

  • Nachtigal MW, Hirokawa Y, Enyeart-vanHouten DL, Flanagan JN, Hammer GD, Ingraham HA . 1998 Cell 93: 445–454

  • Nakagama H, Heinrich G, Pelletier J, Housman DE . 1995 Mol. Cell Biol. 15: 1489–1498

  • Nusse R . 1999 Trends Genet. 15: 1–3

  • Oh S, Song Y, Yim J, Kim TK . 1999 J. Biol. Chem. 274: 37473–37478

  • Patek CE, Little MH, Fleming S, Miles C, Charlieu J-P, Clarke AR, Miyagawa K, Christie S, Doig J, Harrison DJ, Porteous D, Brookes AJ, Hooper ML, Hastie ND . 1999 Proc. Natl. Acad. Sci. USA 96: 2931–2936

  • Pelletier J, Bruening W, Kashtan C, Mauer S, Manivel J, Striegel J, Houghton D, Junien C, Habib R, Pouser L, Fine R, Silverman B, Haber D, Housman D . 1991 Cell 67: 437–447

  • Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie N . 1990 Nature 346: 194–197

  • Quandt K, Frech K, Karas H, Wingender E, Werner T . 1995 Nucleic Acids Res. 23: 4878–4884

  • Rahman N, Abidi F, Ford D, Arbour L, Rapley E, Tonin P, Barton D, Batcup G, Berry J, Cotter F, Davison V, Gerrard M, Gray E, Grundy R, Hanafy M, King D, Lewis I, Ridolfi Luethy A, Madlensky L, Mann J, O'Meara A, Oakhill T, Skolnick M, Strong L, Stratton MR et al . 1998 Hum. Genet. 103: 547–556

  • Rauscher III FJ, Morris JF, Tourneay OE, Cook DM, Curran T . 1990 Science 250: 1259–1262

  • Reddy JC, Licht JD . 1996 Biochim. Biophys. Acta 1287: 1–28

  • Sambrook J, Fritsch EF, Maniatis T . 1989 Cold Spring Harbor Laboratory Press

  • Scharnhorst V, Dekker P, van der Eb AJ, Jochemsen AG . 1999 J. Biol. Chem. 274: 23456–24362

  • Sharma PM, Bowman M, Madden SL, Rauscher III FJ, Sukumar S . 1994 Genes Dev. 8: 720–731

  • Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J . 1997 Cell Growth Differ. 8: 1349–1358

  • Shoyab M, McDonald VL, Bradley JG, Todaro GJ . 1988 Proc. Natl. Acad. Sci. USA 85: 6528–6532

  • Singer-Sam J, LeBon JM, Dai A, Riggs AD . 1992 PCR Methods and Applic. 1: 160–163

  • Slater RM, Mannens MM . 1992 Cancer Genet. Cytogenet. 61: 111–121

  • Stanhope-Baker P, Williams BR . 2000 J. Biol. Chem. 275: 38139–38150

  • Stark K, Vainio S, Vassileva G, McMahon AP . 1994 Nature 372: 679–683

  • Thate C, Englert C, Gessler M . 1998 Oncogene 17: 1287–1294

  • Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP . 1999 Nature 397: 405–409

  • Wang Z, Madden S, Deuel T, Rauscher F . 1992 J. Biol. Chem. 267: 21999–22002

  • Wong GT, Gavin BJ, McMahon AP . 1994 Mol. Cell Biol. 14: 6278–6286

Download references

Acknowledgements

We thank Veronica van Heyningen for provision of the M15 cells, David Porteous for molecular biological advice, Jeff Christianssen for technical support and Clontech for provision of the mouse Atlas arrays. E Szilagi was supported by a UNIMAS academic staff training program scholarship. MH Little is a Senior Research Fellow with the Sylvia and Charles Viertel Foundation. We thank all of the researchers who contributed cDNA clones (http:// www.cmcb.uq.edu.au/pubs/array.html). This work was supported by the National Health and Medical Research Council of Australia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melissa H Little.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sim, EH., Smith, A., Szilagi, E. et al. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene 21, 2948–2960 (2002). https://doi.org/10.1038/sj.onc.1205373

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205373

Keywords

This article is cited by

Search

Quick links